This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Gastrointestinal antispasmodics during breastfeeding

Authoring team

A review states (1):

  • hyoscine butylbromide, propantheline or peppermint oil are considered preferred choices in breastfeeding
    • mebeverine and alverine can also be used
  • there is limited evidence for the use of antispasmodics during breastfeeding, and therefore recommendations are generally made on the properties of the medicine
    • the choice of medicine will depend on symptoms
    • there is a theoretical risk that suppression of breast milk production could occur with antimuscarinic drugs (atropine, hyoscine butylbromide, propantheline)
    • there have been conflicting reports that peppermint may increase or decrease breast milk production
      • there is no published evidence to support this
  • once breastfeeding is established, any effect on breast milk production becomes less significant
  • it is advisable to monitor breastfed infants for adequate feeding and poor weight gain, especially if used long-term

Reference:

  1. NHS Specialist Pharmacy Service (March 8th 2024). Using gastrointestinal antispasmodics during breastfeeding.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.